Mapping Pharmaceutical Clinical Services in Palliative Care Patients.

Objective: To map the role of the pharmacist in palliative care and identify the clinical outcomes associated with these interventions. Introduction: Chronic non-communicable diseases are the leading cause of death in Brazil, creating a significant and growing demand for palliative care. Despite this need, the provision of palliative care services remains insufficient and unequal. Scientific production is crucial to guide public policies, qualify clinical practice, and direct professional training. This review will identify and analyze the scientific production on palliative care and the pharmacist's role in this context. The pharmacist, as part of the multidisciplinary team, plays a crucial role in pharmacotherapy management, prevention of medication errors, and optimization of symptom control. However, the systematization of evidence regarding the clinical impact of this role is still necessary. Inclusion Criteria: Studies addressing the role of the clinical pharmacist in patients under palliative care, regardless of age or care setting (hospital, home, or outpatient). Studies reporting pharmaceutical interventions and clinical, humanistic, or economic outcomes will be included. Methods: A comprehensive search will be conducted in the PubMed, LILACS/BVS, Cochrane Library, and Embase databases, with no date restrictions for the initial search, in order to map historical production. The search for grey literature will include theses and dissertations. Two independent reviewers will select titles, abstracts, and full articles based on the inclusion criteria. Data will be extracted using a standardized form, and the results will be presented in tables, graphs, and a narrative summary corresponding to the objective and the review questions.